Tri­bunal dis­miss­es Boehringer In­gel­heim's li­a­bil­i­ty claim against Sanofi in Zan­tac case

French phar­ma gi­ant Sanofi is not on the hook to in­dem­ni­fy Boehringer In­gel­heim for po­ten­tial li­a­bil­i­ties re­lat­ed to on­go­ing Zan­tac lit­i­ga­tion in the US, an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER